Skip to main content
Clinical Trials/CTRI/2023/06/054099
CTRI/2023/06/054099
Not yet recruiting
Phase 3

To study the efficacy of Dexmedetomidine as an adjuvant to hyperbaric preparations of 0.5% Levobupivacaine, 0.75% Ropivacaine & 0.5% Bupivacaine in the patients undergoing surgeries under subarachnoid block

Department of Anaesthesia and Critical Care0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
Department of Anaesthesia and Critical Care
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Anaesthesia and Critical Care

Eligibility Criteria

Inclusion Criteria

  • Consent from patients and ASA grading I\-II posted for lower abdominal and lower limb surgical procedures planned under subarachnoid block.

Exclusion Criteria

  • Non consenting as well pregnant patients, any spinal deformities, infection at the site,uncontrolled co\-existing systemic and metabolic diseases, history of alcohol abuse, known sensivity to any LAAs and dexmedetomidine shall be excluded from the study , patients on beta blockers and sinus bradycardia

Outcomes

Primary Outcomes

Not specified

Similar Trials